532 related articles for article (PubMed ID: 29514728)
1. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
[TBL] [Abstract][Full Text] [Related]
2. Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States.
Williams PV; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
Dermatol Ther (Heidelb); 2018 Mar; 8(1):69-83. PubMed ID: 29429043
[TBL] [Abstract][Full Text] [Related]
3. Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.
Eghrari-Sabet J; Sher E; Kavati A; Pilon D; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Bernstein JA
Allergy Asthma Proc; 2018 May; 39(3):191-200. PubMed ID: 29458456
[TBL] [Abstract][Full Text] [Related]
4. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria.
Zazzali JL; Broder MS; Chang E; Chiu MW; Hogan DJ
Ann Allergy Asthma Immunol; 2012 Feb; 108(2):98-102. PubMed ID: 22289728
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid-related toxicity in patients with chronic idiopathic urticariachronic spontaneous urticaria.
Ledford D; Broder MS; Antonova E; Omachi TA; Chang E; Luskin A
Allergy Asthma Proc; 2016 Nov; 37(6):458-465. PubMed ID: 27931301
[TBL] [Abstract][Full Text] [Related]
6. Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria.
Broder MS; Raimundo K; Antonova E; Chang E
Am J Clin Dermatol; 2015 Aug; 16(4):313-321. PubMed ID: 26055728
[TBL] [Abstract][Full Text] [Related]
7. Exploring the real-world profile of refractory and non-refractory chronic idiopathic urticaria in the USA: clinical burden and healthcare resource use.
Hoskin B; Ortiz B; Paknis B; Kavati A
Curr Med Res Opin; 2019 Aug; 35(8):1387-1395. PubMed ID: 30793986
[No Abstract] [Full Text] [Related]
8. Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.
Ke X; Kavati A; Wertz D; Huang Q; Wang L; Willey VJ; Stephenson JJ; Ortiz B; Paknis B; Bernstein JA; Beck LA
J Manag Care Spec Pharm; 2018 Jul; 24(7):598-606. PubMed ID: 29952712
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey.
Vietri J; Turner SJ; Tian H; Isherwood G; Balp MM; Gabriel S
Ann Allergy Asthma Immunol; 2015 Oct; 115(4):306-11. PubMed ID: 26265010
[TBL] [Abstract][Full Text] [Related]
10. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
[TBL] [Abstract][Full Text] [Related]
11. Medication patterns in chronic spontaneous urticaria: results from a nationwide investigation in the primary care setting in Italy.
Vena GA; Cassano N; Pegoraro V; Cataldo N; Heiman F; Cricelli I; Colombo D; Zagni E; Cricelli C; Lapi F
G Ital Dermatol Venereol; 2018 Feb; 153(1):39-42. PubMed ID: 27248148
[TBL] [Abstract][Full Text] [Related]
12. Validation of an ICD-9-based claims algorithm for identifying patients with chronic idiopathic/spontaneous urticaria.
Cherepanov D; Raimundo K; Chang E; Eagan M; Zazzali JL; Solari PG; DeCotiis B; Hussain I; Rehman SM; Shahab N; Tilles SA; Broder MS
Ann Allergy Asthma Immunol; 2015 May; 114(5):393-8. PubMed ID: 25771155
[TBL] [Abstract][Full Text] [Related]
13. Unmet medical needs for chronic spontaneous urticaria patients: highlighting the real-life clinical practice in Taiwan.
Cho YT; Pao YC; Chu CY
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):41-9. PubMed ID: 26428436
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients.
Balp MM; Weller K; Carboni V; Chirilov A; Papavassilis C; Severin T; Tian H; Zuberbier T; Maurer M
Pediatr Allergy Immunol; 2018 Sep; 29(6):630-636. PubMed ID: 29679413
[TBL] [Abstract][Full Text] [Related]
15. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.
Weller K; Maurer M; Grattan C; Nakonechna A; Abuzakouk M; Bérard F; Sussman G; Giménez-Arnau AM; Ortiz de Frutos J; Knulst A; Canonica GW; Hollis K; McBride D; Balp MM
Clin Transl Allergy; 2015; 5():29. PubMed ID: 26284152
[TBL] [Abstract][Full Text] [Related]
16. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).
Lacour JP; Khemis A; Giordano-Labadie F; Martin L; Staumont-Salle D; Hacard F; Tian H; McBride D; Hollis K; Hunter S; Martin L; Lamirand A; Le Guen S; Balp MM; Berard F
Eur J Dermatol; 2018 Dec; 28(6):795-802. PubMed ID: 30698148
[TBL] [Abstract][Full Text] [Related]
17. Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Yan S; Chen W; Wen S; Zhu W; Guo A; Chen X; Zhang C; Chen M; Zhang J; Su J; Zhao Y; He Y; Liu Z; Zhou H; Zeng W; Li J; Chen X
J Dermatol Sci; 2014 Dec; 76(3):240-5. PubMed ID: 25455139
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of 'real-world' evidence.
Bernstein JA; Kavati A; Tharp MD; Ortiz B; MacDonald K; Denhaerynck K; Abraham I
Expert Opin Biol Ther; 2018 Apr; 18(4):425-448. PubMed ID: 29431518
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.
Koosakulchai V; Yuenyongviwat A; Sangsupawanich P
Asian Pac J Allergy Immunol; 2022 Jun; 40(2):121-125. PubMed ID: 32061244
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
